How synthetic cannabinoids affect the brain and body
Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences
Researchers are comparing different synthetic cannabinoids to understand why some cause stronger effects and dangerous reactions for people who use them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-10880673 on NIH RePORTER |
What this research studies
Labs in the United States and New Zealand are working together to study how different synthetic cannabinoids interact with the body's cannabinoid system. They will use laboratory assays and animal models to measure molecular actions, how the drugs move through the body, and behavioral and peripheral toxic effects. By mapping structure-activity relationships and ‘molecular fingerprints’, they aim to predict which new compounds are likely to be especially harmful. This work is focused on mechanisms that explain the greater potency and toxicity seen with many synthetic cannabinoids.
Who could benefit from this research
Good fit: People who have used synthetic cannabinoids or who have experienced recent or severe adverse reactions from these substances, and who can provide clinical information or biological samples, would be the most relevant participants.
Not a fit: People without any history of synthetic cannabinoid exposure or whose symptoms are due to unrelated causes are unlikely to directly benefit from this research.
Why it matters
Potential benefit: If successful, this could help clinicians treat poisonings faster and regulators spot and control dangerous new synthetic cannabinoids sooner.
How similar studies have performed: Prior laboratory and animal research has shown some synthetic cannabinoids are more potent and toxic than THC, but many new compounds remain untested so this work builds on existing findings while covering novel substances.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Maitra, Rangan — Research Triangle Institute
- Study coordinator: Maitra, Rangan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.